Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda

Frank Cobelens and colleagues outline key research questions that need to be addressed to maximize the impact of programmatic management of drug-resistant tuberculosis.

Saved in:

Bibliographic Details
Published in:	PLoS medicine Vol. 5; no. 7; p. e150
Main Authors:	Cobelens, Frank G. J, Heldal, Einar, Kimerling, Michael E, Mitnick, Carole D, Podewils, Laura J, Ramachandran, Rajeswari, Rieder, Hans L, Weyer, Karin, Zignol, Matteo
Format:	Journal Article
Language:	English
Published:	United States Public Library of Science 01.07.2008 Public Library of Science (PLoS)
Subjects:	Antitubercular Agents - therapeutic use Care and treatment Case management Clinical Trials Drug resistance Global Health Guidelines and Guidance Humans Infectious Diseases International Health Medical case management Medical research Medicine in Developing Countries Medicine, Experimental Methods Microbiology Multidrug resistant organisms Mycobacterium Pilot projects Public domain Public Health Public Health and Epidemiology Science Policy Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - prevention & control Tuberculosis, Multidrug-Resistant - therapy Working groups United States World Health Tuberculosis, Multidrug-Resistant Research Antitubercular Agents Humans
ISSN:	1549-1676, 1549-1277, 1549-1676
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!